Richter Pharma AG 2023 SR
The report highlights Richter Pharma's sustainability progress and ESG measures for the 2023 fiscal year. Key initiatives include the modernization and expansion of its veterinary pharmaceutical production facility in Wels with a 35 million euro investment focusing on energy efficiency, heat recovery, and photovoltaics. The company also expanded its e-mobility infrastructure, digitized drug documentation to save 60,000 sheets of paper annually, and implemented recycling stations across all sites. Additionally, Richter Pharma began preparing for future CSRD compliance by establishing a double materiality matrix and aligning its disclosures with GRI Standards.
Company: Richter Pharma AG
Sector: Wholesale & retail
Country: Austria
Year: 2023
Type: SR
Pages: 13
Back to company
Richter Pharma AG
Update On The Sustainability Report
The report highlights Richter Pharma's sustainability progress and ESG measures for the 2023 fiscal year. Key initiatives include the modernization and expansion of its veterinary pharmaceutical production facility in Wels with a 35 million euro investment focusing on energy efficiency, heat recovery, and photovoltaics. The company also expanded its e-mobility infrastructure, digitized drug documentation to save 60,000 sheets of paper annually, and implemented recycling stations across all sites. Additionally, Richter Pharma began preparing for future CSRD compliance by establishing a double materiality matrix and aligning its disclosures with GRI Standards.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees